Here are Monday's biggest analyst calls: SpaceX, Nvidia, Apple, CoreWeave, Amazon, Meta, Eli Lilly & more
Here are the biggest calls on Wall Street on Monday: Goldman Sachs upgrades CoreWeave to buy from neutral Goldman said CoreWeave shares are undervalued and that investors should buy the dip. “We upgrade CoreWeave from Neutral to Buy with 73% upside to our price target of $106 (down from $139 prior).” Morgan Stanley names Amazon a top pick Morgan Stanley raised its price target to $350 per share from $335. “Amazon to Top Pick With ~3:1 Risk Reward and 5 Catalysts Ahead.” Read more. Morgan Stanley reiterates SpaceX as overweight Morgan Stanley said it’s bullish ahead of earnings later this week. ” SpaceX’s underappreciated value to investors is its central role in building the Physical Intelligence Economy.” Citizens initiates Resideo at outperform Citizens said the company has plenty of upside. “We initiate coverage of Resideo Technologies, a leading manufacturer of residential sensing and controls solutions…” Morgan Stanley reiterates Meta as overweight The bank raised its price target to $820 per share from $775 on Meta. “While Muse is still capturing ~300K new downloads in the US per day, the DAUs are not scaling as quickly as 14 day retention is ~20%. While not surprising given how early it is in this still developing agentic ecosystem, we look for Muse to keep the pace of product innovation high to drive more use cases and daily habits.” Bernstein upgrades Datadog to outperform from market perform Bernstein sees AI tailwinds for Datadog. “Upgrading on AI-driven tailwind strength.” JPMorgan upgrades Intel to neutral from underweight JPMorgan said the risk/reward is more balanced. “We are upgrading INTC to Neutral from Underweight as the stock approaches our $85 price target where risk/reward is much more balanced as the stock has pulled back ~36% from its peak in June.” Bank of America reiterates Apple at buy Bank of America said its checks show iPhone times are “elongated.” “Our tracking of iPhone ship dates on Apple’s own website, and various carrier websites, indicates that as of Oct 19th, the global average ship time (in days) for the iPhone Duo stands at 82 days.” Morgan Stanley upgrades Boyd Gaming to overweight from equal weight The bank said buy the dip in the gaming company. “Stocks have sold-off across gaming, making it one of the worst performing sub-sectors in our coverage ( & broader consumer). However, demand trends are more nuanced, with Regions/LV Locals more resilient. As such, we upgrade BYD t o OW with ~15% upside potential and favorable risk-adjusted return.” Bank of America upgrades Dow to neutral from underperform Bank of America sees “near term stabilization.” “We are upgrading shares of Dow t o Neutral from Underperform as our view on the macro backdrop has evolved, and a more persistent geopolitical instability in the Middle East has created risk of a higher-for-longer crude oil environment.” JPMorgan reiterates Exxon as overweight JPMorgan raised its price target to $186 per share from $166. ” XOM released its revamped 3Q26 earnings bridge on Friday, which included the typical market and planned impacts from commodity prices, margins, scheduled maintenance, and other external items…” Morgan Stanley upgrades Global-E Online to overweight from equal weight Morgan Stanley said the stock is too cheap to ignore. “With durable 25%+ gross profit growth & likely 3Q GMV upside , GLBE looks too cheap at ~18x ’28 GAAP EPS.” KeyBanc reiterates Nvidia as overweight KeyBanc said it’s bullish on the chipmaker ahead of earnings later this quarter. “We expect NVDA to report higher results and higher guidance, driven by continued acceleration in AI demand across GPUs and increasingly CPUs as agentic AI becomes more prominent.” Canaccord initiates Maze Therapeutics at buy Canaccord said the biotech company is “best in class.” “We are initiating coverage of MAZE s hares with a BUY rating and $75 target.” KeyBanc upgrades Global Payments to overweight from sector weight KeyBanc sees a compelling risk/reward. “We also upgrade GPN to Overweight, where modest growth stabilization, improving cash flow, and capital returns create favorable risk/reward.” Bank of America reiterates Eli Lilly as buy Bank of America raised its price target o n Eli Lilly. “We reiterate our Buy rating and raise our PO to $1,397 (from $1,341), based on 25x P/E (24x prev.) on 2028E underlying EPS, driven by the recent sector re-rating and supportive survey read on category growth and mix.” Evercore ISI upgrades Match to outperform from in line Evercore said the “fundamental trends” are compelling. “We are upgrading MTCH to Outperform from In Line and raising our price target to $53 from $39. Based on Sensor Tower data and our proprietary survey work, we believe Tinder’s user recovery is likely accelerating and tracking ahead of management’s plan for MAU and payer growth by the end of FY27.”
